Atara Biotherapeutics (ATRA) Tax Provisions (2013 - 2026)
Atara Biotherapeutics' (ATRA) quarterly Tax Provisions came in at $28000.0 in Q3 2025, up 264.71% YoY from $7677.4 in Q3 2024, and up 833.33% on a QoQ basis from $3000.0 in Q2 2025.
Atara Biotherapeutics (ATRA) Tax Provisions (2013 - 2026) Analysis & Trends
Atara Biotherapeutics (ATRA) has 13 years of Tax Provisions data on file, last reported at $28000.0 in Q3 2025.
- Quarterly Tax Provisions rose 264.71% year-over-year to $28000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $31000.0 (up 186.11% YoY) and the FY2025 annual result came in at $31000.0, up 358.33% from the prior year.
- Tax Provisions advanced to $28000.0 in Q3 2025, from $3000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $30000.0 in Q4 2021 to a low of -$19000.0 in Q3 2023.
- A 5-year average of $7076.9 and a median of $10000.0 in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2021 — Tax Provisions jumped 1500.0% — and 2023, when it sank 290.0%.
- Tracing ATRA's Tax Provisions over 5 years: stood at $30000.0 in 2021, then plunged by 93.33% to $2000.0 in 2022, then soared by 450.0% to $11000.0 in 2023, then tumbled by 272.73% to -$19000.0 in 2024, then surged by 247.37% to $28000.0 in 2025.
- The last three Tax Provisions figures came in at $28000.0 (Q3 2025), $3000.0 (Q2 2025), and -$19000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Atara Biotherapeutics | 141.08 Mn | 124.53 Mn | 439,000.00 | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,000.00 |
| Dec 31, 2025 | 6.84 Mn |
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | -19,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Dec 31, 2018 | -47,000.00 |